A detailed history of Granite Investment Partners, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Granite Investment Partners, LLC holds 409,786 shares of TXG stock, worth $6.04 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
409,786
Previous 461,013 11.11%
Holding current value
$6.04 Million
Previous $8.97 Million 3.19%
% of portfolio
0.41%
Previous 0.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$15.71 - $23.49 $804,776 - $1.2 Million
-51,227 Reduced 11.11%
409,786 $9.25 Million
Q2 2024

Aug 12, 2024

SELL
$19.45 - $37.37 $933,989 - $1.79 Million
-48,020 Reduced 9.43%
461,013 $8.97 Million
Q1 2024

May 13, 2024

BUY
$36.08 - $54.3 $18.4 Million - $27.6 Million
509,033 New
509,033 $19.1 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.4B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.